<DOC>
	<DOCNO>NCT01489761</DOCNO>
	<brief_summary>This multi-center , randomize , study compare efficacy zotarolimus-eluting stent ( Resolute Integrity Resolute Onyx stent ) everolimus-eluting stent ( Xience Prime Xience Xpedition Xience Alpine stent ) long coronary lesion .</brief_summary>
	<brief_title>LONG-DES VI ( Drug Eluting Stent Long Lesions Coronary Artery )</brief_title>
	<detailed_description>Following angiography , patient significant diameter stenosis &gt; 50 % lesion length ( &gt; 50mm ) require least 2 multiple long-stent placement visual estimation eligible LONG-DES VI trial inclusion exclusion criterion randomize 1:1 zotarolimus-eluting stent ( Resolute Integrity Resolute Onyx stent ) everolimus-eluting stent ( Xience Prime Xience Xpedition Xience Alpine stent ) stratify randomization method .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>Age 20 year Significant native coronary artery stenosis ( &gt; 50 % visual estimate ) lesion length 50mm , require least 2 multiple long stent placement without intervene normal segment Patients silent ischemia , stable unstable angina pectoris , NonSTelevation myocardial infarction ( NSTEMI ) The patient guardian agree study protocol schedule clinical angiographic followup , provide informed , write consent , approve appropriate Institutional Review Board/Ethical Committee respective clinical site Any contraindication follow medication : aspirin , heparin , clopidogrel , stainless steel , contrast agent , zotarolimus , everolimus An elective surgical procedure plan would necessitate interruption antiplatelet drug first 6 month post enrollment Acute STsegmentelevation MI cardiogenic shock Terminal illness life expectancy &lt; 1 year Patients actively participate another drug device investigational study , complete primary endpoint followup period Instent restenosis target vessel ( either bare metal stent drugeluting stent segment ) However , nontarget vessel Instent restenosis permit Patients EF &lt; 30 % Serum creatinine level &gt; =2.0mg/dL dependence dialysis Patients leave main stem stenosis ( &gt; 50 % visual estimate )</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>long lesion</keyword>
	<keyword>drug elute stent</keyword>
</DOC>